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We present a case report of  a patient presenting poste-
rior reversible encephalopathy syndrome (PRES), a rare 
acute neurological condition associated with pre-ec-
lampsia. A possible common aetiology and successful 
clinical management approach is reported. 
PRES is a rare neurological syndrome first described in 
19961. Its clinical manifestation varies and is nonspecif-
ic1. Most PRES patients suffer from headaches, con-
sciousness disorders, seizures, vomiting, mental status 
changes and visual abnormalities1. Its typical imaging 
finding is characterized by a bilateral posterior cerebral 
vasogenic edema, especially in the parietal lobe and oc-
cipital lobe1,2. Pre-eclampsia or eclampsia is the most 
common cause of  PRES3. Most PRES cases associated 
with pre-eclampsia/eclampsia are postpartum and in-
trapartum, rather than antepartum4. Visual abnormali-
ties in PRES commonly include blurred vision, hemian-
opia, visual neglect, etc1. Reversible cortical blindness is 
a very rare symptom5.
A 23-year-old woman (gravida 2, para 1) at week 37+3 
of  gestation was admitted to the Department of  Ob-
stetrics of  the Fourth Hospital of  Shijiazhuang, Chi-
na, with bilateral visual loss accompanied by headache, 
nausea and vomiting with unknown reasons for the past 
4 hours. The first and second trimester had been une-
ventful with no history of  hypertension and epilepsy 
before or during pregnancy. There was no other signif-
icant history.
On admission, all vital signs were normal except her 
blood pressure which was 175/107 mmHg. An ob-
stetric examination confirmed a fetus in a head-down 
position. A color doppler ultrasound showed a single 
live fetus with intrauterine growth retardation and olig-
ohydramnios, and a laboratory test showed proteinuria 
(3+). A diagnosis of  severe pre-eclampsia was made. 
Continuous infusion of  magnesium sulphate at a dose 
of  0.5g/h was immediately administered to the patient 
to relieve vasospasm, and nifedipine and labetalol were 
administered orally to control blood pressure.
As a result of  the reported bilateral visual loss, fun-
doscopic examination was performed by an ophthal-
mologist and slight narrowing of  the retinal artery was 
detected. Cortical blindness was suspected and a cra-
nial MRI examination with diffusion-weighted imaging 
(DWI) was performed with a 1.5 T scanner (Achieva, 
Philips Healthcare, Best, The Netherlands). An 8-chan-
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nelled head-neck coil was used as signal transmitter and 
receiver. The image showed low signal intensity in the 
bilateral frontal lobes, parietal lobes, temporal lobes and 
occipital lobes in T1-weighted images (T1WI). In con-
trast, hyperintense signals were found in T2-weighted 
images (T2WI) and fluid-attenuated inversion recovery 
(FLAIR). Isointensity or slightly increased signals were 
found through DWI. Hyperintense signals showed ap-
parent diffusion coefficient (ADC) maps (Fig. 1), sug-
gesting a diagnosis of  PRES.
Fig. 1 Axial MR imaging in PRES patient with pre-eclampsia. A, T1WI shows roughly symmetric low 
signal intensity located in the bilateral frontal lobes, parietal lobes, temporal lobes and occipital lobes 
(arrows); B and C, T2WI and FLAIR sequence, respectively, both of  which show hyperintense signals in 
the same positions indicated by arrows; D, DWI shows slightly increased signals in the frontal lobes and 
isointense signals in the other lobes (arrows); E, ADC maps reveals hyperintensities in similar regions 
(arrows), which are consistent with the images in vasogenic edema.
After controlling the blood pressure, the patient under-
went a caesarean section 6 hours after admission to the 
hospital, and delivered a 1450 gram baby. The subse-
quent pathological examination showed inflammatory 
cell infiltration in the chorion of  the placenta. Some 
of  the chorion stroma had become marginally fibrotic, 
some showing fibrous necrosis. Inflammatory cell in-
filtration was also found in the fetal membrane. Three 
days after surgery, the patient’s vision recovered, her 
headache disappeared, and blood pressure dropped to 
130/61 mmHg. Eight days later, her wound healed and 
The cause of  pre-eclampsia is unclear, but is known to 
be associated with endothelial damage in the placenta8, 
9. In this case, necrosis and phagocyte infiltration were 
found in the placenta. The diffuse vascular endothelial 
activation and injury, consequent vasoconstriction and 
an increase in endothelial permeability, may induce the 
variable signs of  pre-eclampsia, including vasogenic 
edema of  brain tissue8,9. If  vasogenic edema occurs in 
the visual cortex of  the patient, it may induce cortical 
blindness. 
As PRES improved and resolved after delivery of  the 
baby and the placenta, it is suggested that the culprit 
may be in the placenta3,10.  The endothelial damage not-
ed in the placenta may be paralleled in the endothelial 
damage at the blood-brain barrier with a possible com-
mon aetiology8,9.
It is imperative that clinicians, including obstetricians, 
ophthalmologists and neurologists are familiar with 
variable features and factors of  PRES and its associ-
ation with blindness. A fundoscopy examination is es-
sential to diagnose a patient with pre-eclampsia who 
complains of  ophthalmic symptoms7. If  cerebral oede-
ma is suspected, an MRI must also be performed. In 
PRES, the MRI image shows symmetrical or bilater-
al vasogenic edema in the parietal and occipital lobe. 
Vasogenic edema is also commonly found in the frontal 
lobe, temporal lobe and cerebellar hemisphere1,2. In the 
brain edema area, an MRI image shows hypointense or 
isointense signals in T1WI and hyperintense signals in 
T2WI and FLAIR sequence2,11. The combination of  
DWI and ADC maps can separate vasogenic edema 
from cytotoxic edema, which is critical in the diagnosis 
of  PRES11. The hypointensive or isointensive signals in 
DWI and hyperintensive signals in ADC images indi-
cate the area of  vasogenic edema. The signals in DWI 
sometimes increase slightly due to T2 "shine-through" 
effect in vasogenic edema. In contrast, the hyperinten-
sive signals in DWI and hypointensive signals in ADC 
images indicate the area of  cytotoxic edema. Therefore, 
DWI and ADC maps can diagnose PRES and early 
stage cerebral infarction easily, enabling prompt diag-
nosis, critical to guide therapy and informed prognosis 
of  the patient with PRES12.
The key to treat pre-eclampsia and PRES include con-
trol of  blood pressure, prevention of  seizures, and ter-
mination of  pregnancy13. Antihypertensive treatment 
should be given when the patient’s systolic pressure is 
consistently higher than 160 mmHg or diastolic blood 
she was discharged from the hospital. A final diagnosis 
of  PRES with severe pre-eclampsia was confirmed.
The pathophysiological mechanism of  PRES caused 
by pre-eclampsia is still unclear. One hypothesis is that 
high blood pressure causes cerebrovascular autoregula-
tion failure, resulting in hyperperfusion. Another is that 
hypoperfusion is caused by vasospasm or vasoconstric-
tion6. Vasogenic edema in brain tissue occurs in both 
hypotheses6. Consequently, there is endothelial damage, 
at least in part, at the blood-brain barrier7.
pressure is 105-110 mmHg or above. Common anti-
hypertensive drugs include labetalol, hydralazine and 
short-acting oral nifedipine. The preferred medicine to 
prevent seizures is magnesium sulphate to relieve vas-
cular spasm. As soon as blood pressure is stabilised, the 
pregnancy should be terminated immediately13.
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